Geopolitics Alpha

Market closed · last trade · ETFs, Alpaca IEX

8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: IMDX
  • Market reaction: IMDX −15.7% by the next session

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHA8-K - Insight MolecularDiagnostics Inc. (0001642380)(Filer)IMDXGEOPOLITICS ALPHA

8-K - Insight Molecular Diagnostics filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • IMDX Insight Molecular Diagnostics

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Insight Molecular Diagnostics belongs to, so it often moves with news about it.

  • IDXX IDEXX Laboratories+33.6% 13d

    IDEXX Laboratories is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

  • LNTH Lantheus Holdings+1.3% 30d

    Lantheus Holdings is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

  • NEOG Neogen-6.5% 30d

    Neogen is a peer of Insight Molecular Diagnostics in in vitro and in vivo diagnostic substances; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
IMDX+34.05%+24.32%base-4.32%-15.68%after closeafter close
XLV+0.52%-0.04%base-1.40%-3.58%after closeafter close
IDXX-0.56%-0.37%base-1.49%-0.29%after closeafter close
LNTH-0.12%-0.49%base+0.07%+0.26%after closeafter close
NEOG+7.26%+2.94%base+0.28%+1.93%after closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001493152-26-052323 Size: 449 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Price since this story was published: Insight Molecular Diagnostics (IMDX)

CompanyWhenMoveStatus
IDXXthat day-1.49%final price
IDXXthe next day-0.29%final price
IDXXthree days earlier-0.37%final price
IDXXfive days earlier-0.56%final price
Insight Molecular Diagnostics (IMDX)that day-4.32%final price
Insight Molecular Diagnostics (IMDX)the next day-15.68%final price
Insight Molecular Diagnostics (IMDX)three days earlier+24.32%final price
Insight Molecular Diagnostics (IMDX)five days earlier+34.05%final price
LNTHthat day+0.07%final price
LNTHthe next day+0.26%final price
LNTHthree days earlier-0.49%final price
LNTHfive days earlier-0.12%final price
NEOGthat day+0.28%final price
NEOGthe next day+1.93%final price
NEOGthree days earlier+2.94%final price
NEOGfive days earlier+7.26%final price
XLVthat day-1.40%final price
XLVthe next day-3.58%final price
XLVthree days earlier-0.04%final price
XLVfive days earlier+0.52%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Insight Molecular Diagnostics (IMDX)

Companies carried with this story

  • IMDX Insight Molecular Diagnostics

    In “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer),” Insight Molecular Diagnostics (IMDX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IMDX

Insight Molecular Diagnostics (IMDX)

The 16 Nov 2026 story “8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” names Insight Molecular Diagnostics (IMDX) because of this story.

The link for Insight Molecular Diagnostics (IMDX) is this: SEC 8-K filing -> direct issuer disclosure -> IMDX

What the saved facts support for Insight Molecular Diagnostics (IMDX)

14 out of 100

“8-K - Insight Molecular Diagnostics Inc. (0001642380) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.